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Herpes simplex virus 1 (HSV-1) required cholesterol or desmosterol for virion-inducedmembrane fusion. HSV successfully en-
tered DHCR24/ cells, which lack a desmosterol-to-cholesterol conversion enzyme, indicating that entry can occur indepen-
dently of cholesterol. Depletion of desmosterol from these cells resulted in diminished HSV-1 entry, suggesting a general sterol
requirement for HSV-1 entry and that desmosterol can operate in virus entry. Cholesterol functionedmore effectively than des-
mosterol, suggesting that the hydrocarbon tail of cholesterol influences viral entry.
The host cell plasma membrane poses an initial barrier to viralinfection. Cholesterol is a vital component of eukaryotic
membranes, providing rigidity and reducing permeability. Cho-
lesterol is a key component of lipid rafts, which are specialized
membrane microdomains that play important metabolic roles,
including membrane signaling and sorting. Cholesterol-altering
agents inhibit herpes simplex virus (HSV) entry into several cell
types (1–4). Whether cell membrane cholesterol is specifically re-
quired for HSV membrane fusion is not known.
Although the entry of many viruses is cholesterol dependent
(5–8), the molecular features of cholesterol that are important for
viral entry remain understudied. It is also not known whether
cholesterol’s ability to promote virus entry is shared by related
sterols. In this study, we interrogate the sterol features and re-
quirements that are important for HSV-1 entry by using embry-
onic fibroblasts from mice lacking the DHCR24 gene (9), which
encodes an enzyme necessary for cholesterol synthesis. The
DHCR24/ cells contain the cholesterol precursor desmosterol
and no detectable amounts of cholesterol (10). Desmosterol is
structurally identical to cholesterol with the exception of a C-24 –
C-25 double bond located in the hydrocarbon tail. We show that
desmosterol operates in virus entry, indicating that cholesterol is
not unique among sterols in this regard. However, desmosterol is
apparently less efficient, implicating a functional role for the hy-
drocarbon tail of cholesterol in HSV-1 entry.
To determine more directly the role of cholesterol in HSV in-
fection, we tested the effect of methyl--cyclodextrin (MCD) on
fusion from without (FFWO). Virion-cell fusion during HSV en-
try is difficult to study directly, and FFWO is a surrogate means to
measure membrane fusion induced by the viral particle (11–13).
FFWO is the induction of target cell fusion by the addition of
virions to a cell monolayer surface and does not require viral pro-
tein expression (14). A subset of syncytial strains, including
HSV-1 strain ANG path (a pathogenic variant of strain ANG), has
FFWO activity (Fig. 1A). An ectodomain mutation and a cytoplas-
mic tail syncytial mutation in the HSV fusion glycoprotein gB are
both needed for FFWO (15). There are many similarities between
FFWO and virus-cell fusion during entry (11, 12, 16). The effector
and target membranes for FFWO and entry are the same. Like
viral entry, FFWO requires an appropriate gD receptor (e.g., nec-
tin-1, nectin-2, or herpesvirus entry mediator [HVEM]) in the
target membrane. The efficiency of gD receptor usage for an
FFWO strain correlates with the efficiency of entry mediated by
the same receptor. Finally, antibodies to gB and gD that block
FFWO also neutralize viral entry.
Vero cells were depleted of cell cholesterol with increasing con-
centrations of MCD (Sigma, St. Louis, MO), and then HSV-1
ANG path was added in the presence of cycloheximide (Sigma). At
3 h postinfection (p.i.), photomicrographs were taken and evalu-
ated for FFWO. Cells that were treated with increasing concentra-
tions of MCD supported diminished FFWO (Fig. 1B to D). Sup-
plementing MCD-treated cells with water-soluble cholesterol
(Sigma) restored FFWO (Fig. 1E to H). Quantitation of FFWO
supported the critical role of cholesterol in fusion (Fig. 1I). To-
gether, the results suggest that target membrane cholesterol is re-
quired for herpes simplex virus strain ANG path virion-mediated
membrane fusion.
To probe whether the virus-cell fusion step in the entry process
requires cholesterol, we employed a modified infectivity assay and
Vero cells, the well-studied model cell type that mediates direct
penetration of HSV at the cell surface (17, 18). MCD treatment
of Vero cells, as well as HaCaT cells, keratinocytes, B78-HVEM
cells, and B78-nectin-1 cells, was previously shown to inhibit HSV
entry (2, 3). We added a sodium citrate step to inactivate extracel-
lular virus that has not been taken up into the cell. Cells were
treated with MCD to deplete cholesterol and then washed to
remove the agent. HSV-1 strain KOS was added and allowed to
enter for 1 h. Citrate buffer was then added to inactivate virus that
had not bypassed the plasma membrane. This treatment allows a
more direct determination of the effect of MCD on HSV pene-
tration of the cell surface. Plaque formation was determined at 18
h p.i. Treatment of Vero cells with MCD resulted in a decrease in
HSV infectivity in an MCD concentration-dependent manner
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(Fig. 1J), suggesting that the membrane fusion step in Vero cell
entry requires cholesterol. A citrate inactivation test in B78-
nectin-1 cells, which support endocytic entry of HSV (19), con-
firmed that MCD treatment reduced infectivity in these cells
(Fig. 1K) (2).
To investigate the sterol requirements and features that are
important for viral entry, we examined the mechanism of HSV
entry into embryonic fibroblasts from mice lacking the DHCR24
gene, which encodes an enzyme necessary for cholesterol syn-
thesis. The DHCR24/ cells contain the cholesterol precursor
desmosterol, which can function in a manner similar to cho-
lesterol in some cellular processes (e.g., cell proliferation [20])
but not in others (e.g., insulin signaling [21]). Desmosterol is
structurally very similar to cholesterol, with the exception of a
double bond at carbon 24 located in the hydrocarbon tail of
desmosterol (Fig. 2A).
We queried whether desmosterol could function in place of
cholesterol in viral entry. DHCR24/ cells adapted to serum-free
fibroblast basal medium (ATCC, Manassas, VA) contain des-
mosterol and no detectable cholesterol (10). HSV entered
DHCR24/ cells in a multiplicity of infection (MOI)-dependent
manner (Fig. 2B), suggesting that entry can occur in the absence of
cholesterol. MCD also effectively depletes desmosterol from
lipid bilayers. Sterol depletion of DHCR24/ cells by 50 mM
MCD treatment resulted in a 80% reduction in HSV entry
(Fig. 2C) at all MOIs tested, suggesting that sterols in general are
important for viral entry. Depletion was confirmed by an Amplex
red cholesterol assay (Molecular Probes, Eugene, OR) using an
Infinite M1000 pro microplate reader (Tecan, Mannedorf, Swit-
zerland) (Fig. 2D). The Amplex red assay detects both cholesterol
and desmosterol due to their similar structures (Fig. 2A). When
depleted cells were replenished for 30 min with desmosterol
(Sigma), HSV entry was rescued (Fig. 2C). Rescue was accompa-
nied by restored sterol levels (Fig. 2D). These results suggest a
general sterol requirement for HSV-1 entry and suggest that des-
mosterol in particular can function in viral entry. We investigated
a role for desmosterol in membrane fusion using the FFWO assay.
Vero cells treated with MCD supported diminished levels of
HSV-induced FFWO (Fig. 1A to I and 2E), but when MCD-
treated cells were replenished with desmosterol, FFWO was par-
tially restored (Fig. 2E). The effects of MCD and of replenish-
ment were both statistically significant (Student’s t test, P 
0.0001). This suggests that desmosterol can function in virion-
induced cell-cell fusion.
To better gauge the contribution of cholesterol to HSV entry,
we analyzed DHCR24/ cells that were propagated in the
presence of water-soluble cholesterol. HSV entered the cholester-
ol-supplemented DHCR24/ cells (desmosterol and choles-
terol positive [10]) more effectively than the cholesterol-free
DHCR24/ cells (Fig. 3A), which contain desmosterol. Both cell
preparations had a similar total sterol content when assayed by
Amplex red (Fig. 3B). Cells tightly regulate overall sterol levels and
FIG 1 Role of plasma membrane cholesterol in virion-induced fusion. Vero cells were mock treated (A, E) or treated with 5 mM (B, F), 30 mM (C, G), or 50 mM
MCD (D, H) for 30 min at room temperature. Cells were washed twice with phosphate-buffered saline (PBS) and were then either mock treated (A to D) or
treated with 200g/ml water-soluble cholesterol (E to H) for 30 min at 37°C. Then, cells were washed twice with PBS, and HSV-1 strain ANG path (MOI of 100)
was added for 3 h at 37°C in the presence of 0.5 mM cycloheximide (Sigma) (A to H). Cells were fixed with 100% methanol and stained with Giemsa (Sigma).
Magnification,20. (I) Fusion activity is defined as a/b 100, where a the number of nuclei sharing a cytoplasm with at least two other nuclei and b total
nuclei. More than 500 nuclei were evaluated per experimental condition. Each drug treatment was tested in triplicate in at least two independent experiments.
(J, K) Vero (J) or B78-nectin-1 cells (K) in 24-well culture dishes were treated with MCD for 30 min at room temperature. Cells were rinsed with PBS and then
with complete Dulbecco modified Eagle medium. HSV-1 strain KOS (100 PFU) was added for 1 h at 37°C to allow viral entry. Cells were treated with sodium
citrate (pH 3) to inactivate virus that remained at the plasma membrane. At 18 h p.i., cultures were fixed and plaque formation was determined by immuno-
peroxidase staining with anti-HSV polyclonal antibody HR50 (Fitzgerald Industries, Concord, MA). Data are mean results of duplicate determinations. Results
are representative of at least three independent experiments.
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preferentially incorporate cholesterol into membranes (10, 22).
The addition of exogenous cholesterol to DHCR24/ desmos-
terol-containing cells elicits a sterol feedback response, inhibiting
cellular desmosterol synthesis. This may explain why the addition
of cholesterol did not increase the total sterol content of
DHCR24/ cells in the experiments whose results are shown in
Fig. 3A.
In contrast, when parental mouse embryo fibroblasts (MEFs)
(DHCR24	/	 cells), which contain the DHCR24 gene and normal
levels of cholesterol, were supplemented with water-soluble cho-
lesterol in the same manner, viral entry was not increased (Fig.
3C), suggesting that added cholesterol does not nonspecifically
enhance entry. Culturing Vero cells or B78-nectin-1 cells in me-
dium supplemented with cholesterol also resulted in levels of
HSV-1 entry similar to the levels in nonsupplemented cells (data
not shown). These results suggest that cholesterol may be more
effective than desmosterol in HSV entry.
HSV entry into DHCR24/ cells and DHCR24	/	 cells was
detected at similar levels (Fig. 3D). However, the sterol content of
DHCR24/ cells was approximately twice that of the
DHCR24	/	 cells (Fig. 3E), further suggesting that cholesterol is
more efficient than desmosterol in facilitating HSV entry. To-
gether, our results suggest that the hydrocarbon tail of sterol moi-
eties influences viral entry. The results further suggest that HSV
entry relies on cholesterol, yet in its absence, another sterol, such
as desmosterol, can function (Fig. 2B and C and 3A).
DHCR24/ cells provide a unique system to evaluate the im-
portance of cholesterol in the HSV infectious cycle. HSV-1 strain
KOS was added (MOI of 5) to DHCR24/ or DHCR24	/	 cells
in a one-step growth curve assay over a 24-h period. Compared to
cholesterol-containing cells (DHCR24	/	), cells containing des-
mosterol in place of cholesterol (DHCR24/) produced 
5- to
7-fold less infectious HSV-1 following the eclipse phase (Fig. 4A).
DHCR24/ cells also produced less infectious virus than
DHCR24/ cells supplemented with cholesterol (Fig. 4B). Thus,
despite similar levels of viral entry into DHCR24/ and
DHCR24	/	 cells (Fig. 3D), desmosterol may delay HSV-1
growth kinetics. This highlights the importance of the hydrocar-
bon tail for sterol functions during the viral life cycle. HSV-1 mat-
uration and egress involve multiple membrane events. The differ-
ent sterol components of these membranes may explain the delay
in growth kinetics (Fig. 4).
Cholesterol is important for the entry of many viruses, includ-
ing the alphaherpesviruses (2, 4, 23–26). The cholesterol-deficient
DHCR24/ cells allow the contribution of cholesterol to be eval-
uated without the need for pharmacologic treatments, which can
have unwanted off-target effects. The results of the present study
suggest that cell surface sterols are required for HSV membrane
fusion (Fig. 1A to I). Functional roles for cholesterol specifically
and sterols in general in individual entry events may include me-
diating appropriate membrane rigidity and allowing proper virus-
receptor interactions or protein-lipid interactions. Cholesterol is
oriented in the bilipid membrane with its hydrocarbon tail at the
interface of the outer and inner leaflets. The double bond in des-
FIG 2 Desmosterol functions in HSV-1 entry. (A) Final step in the Bloch pathway of cholesterol biosynthesis showing reduction of the 24 –25 double bond in
the hydrocarbon tail of desmosterol by 24-dehydrocholesterol reductase (DHCR24) to form cholesterol. (B) DHCR24/ cells were subcultured in 96-well plates
in basal fibroblast medium. HSV-1 strain KOS tk12, which contains the lacZ gene under an HSV-inducible promoter, was added at different MOIs for 7 h at 37°C.
Cell lysates were prepared using 0.5% Nonidet P-40 (Sigma), chlorophenol red--D-galactopyranoside (Roche Diagnostic, Indianapolis, IN) was added, and the
-galactosidase activity was read at 595 nm with an ELx808 microtiter plate reader (BioTek Instruments, Winooski, VT). -Galactosidase activity indicated
successful entry. Data are mean results of quadruplicate determinations with standard deviations. Results are representative of at least three independent
experiments. (C) DHCR24/ cells were either untreated or treated with 50 mM MCD (Sigma) for 30 min at room temperature. One set of treated cells was
replenished with 200g/ml desmosterol (Sigma) for 30 min at room temperature. Samples treated with MCD only were treated with chloroform diluted 1:500
as a vehicle control. HSV-1 KOS tk12 was added, and entry determined as described above. Entry into DHCR24/ cells was normalized to 100%. Results are
representative of at least three independent experiments. Entry into MCD-treated cells was significantly different from entry into untreated cells (P 0.001 or
P 0.0001, Student’s t test) and from entry into cells replenished with desmosterol (P 0.0001). (D) Sterol levels of cells treated in parallel with those in the
experiment whose results are shown in panel C were quantified with an Amplex red cholesterol assay kit. Sterol content of untreated DHCR24/ cells was set
to 100%. Data are mean results of triplicate determinations with standard deviations. (E) Desmosterol can function in virion-induced membrane fusion. Vero
cells were mock treated or treated with 50 mM MCD for 30 min at room temperature. Cells were washed twice with PBS and were then either mock treated or
treated with 200 g/ml desmosterol for 30 min at 37°C. HSV-1 ANG path was added, and FFWO was assessed as described in the legend to Fig. 1.
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mosterol causes greater tilt in the sterol structure that results in
decreased membrane lipid packing and ordering, thus altering
membrane properties such as fluidity (27). Desmosterol’s effect
on membrane architecture may adversely influence the mem-
brane flexibility necessary for membrane fusion.
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